Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the …

S Singh-Phulgenda, R Kumar, P Dahal… - PLOS Neglected …, 2024 - journals.plos.org
Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis which can occur
after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL …

Fixed-dose artesunate–amodiaquine combination vs chloroquine for treatment of uncomplicated blood stage P. vivax infection in the Brazilian Amazon: an open-label …

AM Siqueira, AC Alencar, GC Melo… - Clinical infectious …, 2017 - academic.oup.com
Background. Despite increasing evidence of the development of Plasmodium vivax
chloroquine (CQ) resistance, there have been no trials comparing its efficacy with that of …

Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa

A Takyi, VI Carrara, P Dahal, M Przybylska… - PLOS Global Public …, 2023 - journals.plos.org
Selection of resistant malaria strains occurs when parasites are exposed to inadequate
antimalarial drug concentrations. The proportion of uncomplicated falciparum malaria …

Maximizing antimalarial efficacy and the importance of dosing strategies

JG Beeson, P Boeuf, FJI Fowkes - BMC medicine, 2015 - Springer
Artemisinin-based combination therapies (ACTs) are the cornerstone for the treatment of
malaria. However, confirmed resistance to artemisinins in South-East Asia, and reports of …

[PDF][PDF] Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa. PLOS Glob Public Health 3 (12): e0002059

A Takyi, VI Carrara, P Dahal, M Przybylska… - 2023 - access.archive-ouverte.unige.ch
Selection of resistant malaria strains occurs when parasites are exposed to inadequate
antimalarial drug concentrations. The proportion of uncomplicated falciparum malaria …